Literature DB >> 20872024

Can malignant bowel obstruction in advanced cancer patients be treated at home?

Giampiero Porzio1, Federica Aielli, Lucilla Verna, Brigida Galletti, Ghazaleh Shoja E Razavi, Corrado Ficorella.   

Abstract

Eleven advanced cancer patients affected by malignant bowel obstruction (MBO) were treated at home with a combination of octreotide, metoclopramide, morphine, and dexamethasone. In all patients, we observed a prompt control of gastrointestinal symptoms and recovery of bowel movements within 1-5 days. Based on our results, a combination of drugs with different mechanisms of action allows an effective and safe treatment for MBO at home. Further studies with larger number of patients are warranted to confirm these preliminary data.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20872024     DOI： 10.1007/s00520-010-1009-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  9 in total

1.  Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer.

Authors:  C Ripamonti; R Twycross; M Baines; F Bozzetti; S Capri; F De Conno; B Gemlo; T M Hunt; H B Krebs; S Mercadante; R Schaerer; P Wilkinson
Journal:  Support Care Cancer       Date:  2001-06       Impact factor: 3.603

2.  Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care.

Authors:  M Maltoni; O Nanni; M Pirovano; E Scarpi; M Indelli; C Martini; M Monti; E Arnoldi; L Piva; A Ravaioli; G Cruciani; R Labianca; D Amadori
Journal:  J Pain Symptom Manage       Date:  1999-04       Impact factor: 3.612

3.  The challenge of treating malignant bowel obstruction.

Authors: 
Journal:  J Support Oncol       Date:  2006-02

4.  Tolerability of continuous subcutaneous octreotide used in combination with other drugs.

Authors:  S Mercadante
Journal:  J Palliat Care       Date:  1995       Impact factor: 2.250

5.  Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction.

Authors:  S Mercadante; C Ripamonti; A Casuccio; E Zecca; L Groff
Journal:  Support Care Cancer       Date:  2000-05       Impact factor: 3.603

Review 6.  Palliative management of malignant bowel obstruction.

Authors:  Carla Ripamonti; Eduardo Bruera
Journal:  Int J Gynecol Cancer       Date:  2002 Mar-Apr       Impact factor: 3.437

7.  Bowel obstruction in home-care cancer patients: 4 years experience.

Authors:  S Mercadante
Journal:  Support Care Cancer       Date:  1995-05       Impact factor: 3.603

8.  Management of malignant bowel obstruction.

Authors:  Carla Ida Ripamonti; Alexandra M Easson; Hans Gerdes
Journal:  Eur J Cancer       Date:  2008-03-21       Impact factor: 9.162

9.  Aggressive pharmacological treatment for reversing malignant bowel obstruction.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Patrizia Villari; Antonio Marrazzo
Journal:  J Pain Symptom Manage       Date:  2004-10       Impact factor: 3.612
  9 in total
  8 in total

1.  Palliative care in advanced cancer patients: how and when? And where?

Authors:  Giampiero Porzio; Sebastiano Mercadante; Federica Aielli; Lucilla Verna; Corrado Ficorella
Journal:  Oncologist       Date:  2012-05-17

Review 2.  Home parenteral nutrition for people with inoperable malignant bowel obstruction.

Authors:  Anne Marie Sowerbutts; Simon Lal; Jana Sremanakova; Andrew Clamp; Chris Todd; Gordon C Jayson; Antje Teubner; Anne-Marie Raftery; Eileen J Sutton; Lisa Hardy; Sorrel Burden
Journal:  Cochrane Database Syst Rev       Date:  2018-08-10

3.  Outcome prognostic factors in inoperable malignant bowel obstruction.

Authors:  Margarita Romeo; Maria de Los LLanos Gil; José Luís Cuadra Urteaga; Laia Vilà; Sara Ahlal; Alberto Indacochea; Núria Pardo; Joaquim Radua; Albert Font; Albert Tuca
Journal:  Support Care Cancer       Date:  2016-06-10       Impact factor: 3.603

Review 4.  [Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients : a systematic literature review].

Authors:  C Klein; S Stiel; J Bükki; C Ostgathe
Journal:  Schmerz       Date:  2012-09       Impact factor: 1.107

5.  Acute impact of home parenteral nutrition in patients with late-stage cancer on family caregivers: preliminary data.

Authors:  Lidia Santarpia; Federico Bozzetti
Journal:  Support Care Cancer       Date:  2017-09-18       Impact factor: 3.603

Review 6.  The role of parenteral nutrition in patients with malignant bowel obstruction.

Authors:  Federico Bozzetti
Journal:  Support Care Cancer       Date:  2019-07-17       Impact factor: 3.603

7.  A scoring system for the prognosis and treatment of malignant bowel obstruction.

Authors:  Jon C Henry; Severin Pouly; Rachael Sullivan; Suhail Sharif; Dori Klemanski; Sherif Abdel-Misih; Nicole Arradaza; David Jarjoura; Carl Schmidt; Mark Bloomston
Journal:  Surgery       Date:  2012-08-26       Impact factor: 3.982

Review 8.  Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.

Authors:  Yeh Chen Lee; Nazlin Jivraj; Catherine O'Brien; Tanya Chawla; Eran Shlomovitz; Sarah Buchanan; Jenny Lau; Jennifer Croke; Johane P Allard; Preeti Dhar; Stephane Laframboise; Sarah E Ferguson; Neesha Dhani; Marcus Butler; Pamela Ng; Terri Stuart-McEwan; Pamela Savage; Lisa Tinker; Amit M Oza; Stephanie Lheureux
Journal:  Obstet Gynecol Int       Date:  2018-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.